Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Contrera KJ, Gule-Monroe M, Hu MI, Cabanillas M, et al. Thyroid 2022 Dec 11. doi: 10.1089/thy.2022.0506.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Contrera KJ, Gule-Monroe M, Hu MI, Cabanillas M, et al. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 2022 Dec 11. doi: 10.1089/thy.2022.0506.
PMID: 36503246